100CFU™ Sensitivity Standards

$733.50
Tax excluded

Files to download:

100CFU™ Sensitivity Standards Technical Note for 100CFU™ Sensitivity Standards

Technical Notes are accessible for our clients, or can be obtained by e-mail.
>> Register an account
Or please provide your e-mail address:

The e-mail seems to be incorrect
send Technical Note
close
cancel Unfortunately an error orcurred and the Technical Note has not been sent.
You can try again, if the problem presists please contact us at info@minerva-biolabs.com
Try again
close
check_circle Technical Note has been sucesfully sent.
Newsletter:
close
close

100CFU™ Sensitivity Standards are designed as complementary products to the 10CFU™ Sensitivity Standards (Cat. No. 102-XX03) to perform the validation of nucleic acid amplification technology (NAT)-based tests for mycoplasma detection.

The European Pharmacopoeia Chapter 2.6.7 (EP 2.6.7) and the Japanese Pharmacopoeia (JP G3, 17th Edition) require NAT-based tests (e.g. PCR) to detect 10 Colony Forming Units per ml of sample volume (CFU/ml). The testing facility must perform an in-house method validation for the selected sample matrix (matrix validation). This process aims at verifying the test’s compliance in terms of sensitivity and robustness and generally requires one or more mycoplasma spikes. However, for most cell culture and production facilities, culturing or handling viable mycoplasma as reference tools is inadmissible.

Our 100CFU™ Sensitivity Standards contain irreversibly inactivated mycoplasma (amount corresponding to 100 CFU) and provide an additional test concentration to the 10CFU™ Sensitivity Standards for the validation of PCR-based detection tests. Including this supplementary concentration in the matrix validation procedure significantly improves the confidence of the tested method.

The Certificate of Analysis provides the specific genome units (GU) to CFU ratio for each lot.

Recommended Use

100CFU™ Sensitivity Standards are intended as complementary products to the 10CFU™ Sensitivity Standards to validate the robustness and sensitivity of NAT-based mycoplasma tests.

Content

3 vials containing 100 CFU of the particular mycoplasma as well as 2 vials negative control. The components are lyophilized.

Available Species and Ordering Information
  • Cat. No. 103-1003 Mycoplasma arginini
  • Cat. No. 103-2003 Mycoplasma orale
  • Cat. No. 103-3003 Mycoplasma gallisepticum
  • Cat. No. 103-4003 Mycoplasma pneumoniae
  • Cat. No. 103-1103 Mycoplasma salivarium
  • Cat. No. 103-5003 Mycoplasma synoviae
  • Cat. No. 103-6003 Mycoplasma fermentans
  • Cat. No. 103-7003 Mycoplasma hyorhinis
  • Cat. No. 103-8003 Acholeplasma laidlawii
  • Cat. No. 103-9003 Spiroplasma citri
Result Evaluation

Application of a PCR-based mycoplasma test, e.g. Venor®GeM qEP Mycoplasma Detection kit (Cat. No. 11-9025 / 11-9100 / 11-9250)

Required Consumables
Required Lab Devices
  • Microcentrifuge
  • Pipetting equipment
Shelf Life and Storage

The date of expiry of the unopened product is given on the package label. The components must be stored until use at +2 to +8 °C. The product is shipped at ambient temperature.